Ian Marschner

Professor Ian Marschner is Professor of Biostatistics and Director of the Biostatistics group at the NHMRC Clinical Trials Centre within the Faculty of Medicine and Health at the University of Sydney. He holds a BSc (Hons) and a PhD in Statistics from La Trobe University, completed in 1991. With over 30 years of experience as a biostatistician, Marschner applies biostatistics to clinical trials, clinical epidemiology, and public health research, with particular focus on cardiovascular disease, oncology, HIV/AIDS, and the development of new statistical methodologies for the design and analysis of clinical trials. His fields of research include biostatistics, cancer therapy excluding chemotherapy and radiation therapy, clinical sciences, chemotherapy, statistics, intensive care, oncology and carcinogenesis, endocrinology, liquid biopsies, and epidemiological methods. He has authored over 150 peer-reviewed research publications, including highly cited works such as 'A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache' (Spine, 2002), 'Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial' (The Lancet, 2001), 'Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials' (The Lancet, 2019), and 'Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy' (PLoS ONE, 2012).

Marschner's career includes previous roles as Associate Professor of Biostatistics at Harvard University, Professor and Head of the Department of Statistics at Macquarie University, and Director of the Asia Biometrics Centre at Pfizer. He has been Chief Investigator on research grants totaling over $20 million, including the Australian Trials Methodology Research Network (AusTriM), an NHMRC Centre of Research Excellence. Marschner has taught statistics courses at all levels from first-year undergraduate to Masters and has supervised PhD students on a range of biostatistical research topics. His work contributes to advancements in clinical trial methodology, such as confidence distributions for treatment effects and analysis of adaptive platform trials.

Professional Email: ian.marschner@sydney.edu.au